TF and Alzheimer disease: Although measurements of AD relapse through telephone interviews have been validated and used in some previous studies (Glass et al., 2017; Moos & Moos, 2006), they could be further validated in this Chinese patient group with the assistance of laboratory test indicators, such as serum ethanol concentration and carbohydrate-deficient transferrin (CDT) (Bortolotti et al., 2018).